EUVIMEDObjevte EUVIMED
Beobachtungsstudie

Predictive factors of genetic diagnosis and real‐life impact of next‐generation sequencing for children with epilepsy

Gustavo Moura da Mata Machado Ferreira Pinto iD, Solena Ziemer Kusma Fidalski iD, Mara Lúcia Schmidt Ferreira Santos iD, Josiane de Souza iD, Daniel Almeida do Valle iD

Epileptic Disorders · 2023

DOI: 10.1002/epd2.20131 ↗

At a glance

Beobachtungsstudie in Epileptic Disorders, 2023. Written by Gustavo Moura da Mata Machado Ferreira Pinto and 4 co-authors. Institution: Department of Pediatrics, Hospital Pequeno Principe, Curitiba, Brazil. Major MEDLINE topics: Epilepsy, Genetic Testing, High-Throughput Nucleotide Sequencing. Cited 4 times so far (Crossref); 15 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Identify the predictive variables of genetic pathogenic results and the impact of test results on epilepsy diagnosis and management.

Methods

Analytical observational design evaluated 130 patients with epilepsy that had performed genetic testing over January 2017 to July 2022.

Results

There was a gradual increase in the number of exams performed over the years. The frequency of pathogenic results was 34% ( n = 44/130), 8 altered genes with 54% ( n = 24/44) of the results. The tests were more positive in patients with developmental delay and/or regression ( p = .01). None of the other factors analyzed were associated with higher diagnostic yield. The age at onset of epilepsy brought diagnostic yield to the test ( p = .041). Patients with negative genetic test had a reduction in the number of electroencephalograms performed before and after the test (respectively, 3.80 ± 6.37 and .84 ± 1.67; p < .001). Significance Facing a large proportion of patients with unexplained epilepsy have a genetic cause a genetic test has the potential to reduce the use of unnecessary diagnostic tests, improve patient outcomes by identifying targeted treatments, and provide families with genetic counseling and risk assessment. But an early genetic testing can be crucial to reach these goals. Even in cases where the genetic test is negative, the study suggests that it still has important implications for patient care and management.

Subjects

MeSH terms (MEDLINE)

EpilepsyGenetic TestingHigh-Throughput Nucleotide SequencingHumansChildFemaleMaleChild, PreschoolAdolescentElectroencephalographyInfant

Author keywords

DNA sequence analysisclinical outcomeepilepsynext-generation sequencingprecision therapy

Authors and institutions

  • Department of Pediatrics, Hospital Pequeno Principe, Curitiba, Brazil.
  • Department of Pediatric Neurology, Hospital Pequeno Principe, Curitiba, Brazil.
  • Department of Clinical Genetics, Hospital Pequeno Principe, Curitiba, Brazil.
  • Universidade Positivo, Curitiba, Brazil.

ORCID profiles: Gustavo Moura da Mata Machado Ferreira Pinto, Solena Ziemer Kusma Fidalski, Mara Lúcia Schmidt Ferreira Santos, Josiane de Souza, Daniel Almeida do Valle

Cite

APA

Pinto, G. M. D. M. M. F., Fidalski, S. Z. K., Santos, M. L. S. F., de Souza, J., & do Valle, D. A. (2023). Predictive factors of genetic diagnosis and real‐life impact of next‐generation sequencing for children with epilepsy. Epileptic Disorders. https://doi.org/10.1002/epd2.20131

Vancouver

Pinto GMDMMF, Fidalski SZK, Santos MLSF, de Souza J, do Valle DA. Predictive factors of genetic diagnosis and real‐life impact of next‐generation sequencing for children with epilepsy. Epileptic Disorders. 2023. doi:10.1002/epd2.20131

BibTeX
@article{Pinto2023,
  author = {Pinto, Gustavo Moura da Mata Machado Ferreira and Fidalski, Solena Ziemer Kusma and Santos, Mara Lúcia Schmidt Ferreira and de Souza, Josiane and do Valle, Daniel Almeida},
  title = {Predictive factors of genetic diagnosis and real‐life impact of next‐generation sequencing for children with epilepsy},
  journal = {Epileptic Disorders},
  year = {2023},
  doi = {10.1002/epd2.20131}
}
Start for free →